MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 5th-6th October 2023 at The Westin Grand Frankfurt, Germany. This event is designed to provide forward-looking insights into the latest trends and tools impacting biomarker research, it brings together leading experts from global pharmaceutical organisations, innovative biotech companies and internationally renowned academic institutions working across multiple therapeutic areas and stages of drug development.
This conference unites advances in biomarker use for drug discovery and development, alongside biomarkers for cancer. The Expert Panel will take you through their presentations which will include problems, solutions and services in the Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases. Attendees would evidence the examples and the case studies which will help in creating the revenue. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.
Technical and Applications Manager, Proteome Sciences
Biomarker Experimental Medicine Leader, Oncology, Roche
Senior scientist BioSensing & Diagnostics (BSD) , Wageningen UR
Associate Professor, Aalborg University
Founder, CEO, Predicine
Clinical Senior Lecturer, Imperial College London
Global Biomarker Lead, Novartis
Head, Oncology Bioinformatics, Merck Healthcare, Germany
Post Doctoral Research Fellow, University of Oxford
Lecturer, Clinical Genetics, University of Derby
Chief Scientific Officer, Step Pharma
Executive Director Patient Engagement, Cardiovascular, Renal & Metabolism Patient Engagement, Novartis
Global Pricing & Market Access Director, Oncology Diagnostics,, AstraZeneca
The Westin Grand Frankfurt, Germany